Literature DB >> 31737352

Potential clinical utility of multiple target quantitative polymerase chain reaction (qPCR) array to detect microbial pathogens in patients with chronic obstructive pulmonary disease (COPD).

Hannah E O'Farrell1, Janet G Shaw1, Felicia Goh1, Rayleen V Bowman1, Kwun M Fong1, Lutz Krause2, Ian A Yang1.   

Abstract

BACKGROUND: Culture-independent methods such as quantitative polymerase chain reaction (qPCR) are more sensitive for detecting pathogens than conventional culture. This study aimed to test the clinical potential of a multiple target qPCR array in identifying sputum pathogens, compared to traditional culture.
METHODS: Forty chronic obstructive pulmonary disease (COPD) patients provided spontaneous sputum and blood samples during an exacerbation event (n=25 patients) and in stable state (n=15 patients). Sputum was processed and analysed by microscopy, culture and sensitivity testing (MCS) to identify living microbial isolates, and multiple target qPCR (44 targets for bacterial and fungal pathogens and antibiotic resistance genes), and 16S rRNA gene sequencing.
RESULTS: Six microbial isolates (5 bacterial, 1 fungal) were cultured from 20 exacerbation and 10 stable patient sputum samples. Four of these microbial isolates had their presence in patient sputum confirmed by qPCR. All bacterial targets detected by qPCR were further confirmed by 16S rRNA gene sequencing at a genus level. qPCR identified significantly more bacterial pathogens than culture (P<0.001). The most prevalent bacterial species identified by qPCR were Streptococcus pneumoniae (72% of patients), Pseudomonas aeruginosa (40%), Prevotella oris (32%) and Haemophilus influenzae (17%). Microbial species diversity and richness were not significantly different between samples obtained from exacerbating and clinically stable cases. 16S rRNA gene sequencing identified Pseudomonas 4408227 (P=0.022, FDR =0.043 AUC =0.72) as a significantly different bacterial OTU (operational taxonomic units) in exacerbation sputum samples compared to stable state samples.
CONCLUSIONS: Multiple target qPCR was more sensitive for detection of sputum pathogens in COPD patients than conventional culture. 16S rRNA gene sequencing confirmed the identity at a genus level of all bacterial targets detected by qPCR, as well as identifying bacterial OTUs that could potentially be used to distinguish between exacerbation and stable COPD disease states. Multiple target qPCR pathogen detection in the sputum of COPD patients warrants further investigation to determine how it may influence COPD clinical management. 2019 Journal of Thoracic Disease. All rights reserved.

Entities:  

Keywords:  Chronic obstructive pulmonary disease (COPD); exacerbations; microbiome; sputum

Year:  2019        PMID: 31737352      PMCID: PMC6831922          DOI: 10.21037/jtd.2019.10.39

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  34 in total

Review 1.  Rothia mucilaginosa pneumonia: a literature review.

Authors:  Sofia Maraki; Ioannis S Papadakis
Journal:  Infect Dis (Lond)       Date:  2015-03

Review 2.  COPD exacerbations . 2: aetiology.

Authors:  E Sapey; R A Stockley
Journal:  Thorax       Date:  2006-03       Impact factor: 9.139

3.  Evaluation of real-time PCR for the detection and quantification of bacteria in chronic obstructive pulmonary disease.

Authors:  Tanya Curran; Peter V Coyle; Terence E McManus; Joe Kidney; Wilson A Coulter
Journal:  FEMS Immunol Med Microbiol       Date:  2007-04-17

4.  Susceptibility to exacerbation in chronic obstructive pulmonary disease.

Authors:  John R Hurst; Jørgen Vestbo; Antonio Anzueto; Nicholas Locantore; Hana Müllerova; Ruth Tal-Singer; Bruce Miller; David A Lomas; Alvar Agusti; William Macnee; Peter Calverley; Stephen Rennard; Emiel F M Wouters; Jadwiga A Wedzicha
Journal:  N Engl J Med       Date:  2010-09-16       Impact factor: 91.245

5.  Lung microbiota and bacterial abundance in patients with bronchiectasis when clinically stable and during exacerbation.

Authors:  Michael M Tunney; Gisli G Einarsson; Lan Wei; Maire Drain; Erich R Klem; Chris Cardwell; Madeleine Ennis; Richard C Boucher; Matthew C Wolfgang; J Stuart Elborn
Journal:  Am J Respir Crit Care Med       Date:  2013-05-15       Impact factor: 21.405

6.  Changes in prevalence and load of airway bacteria using quantitative PCR in stable and exacerbated COPD.

Authors:  Davinder S Garcha; Sarah J Thurston; Anant R C Patel; Alexander J Mackay; James J P Goldring; Gavin C Donaldson; Timothy D McHugh; Jadwiga A Wedzicha
Journal:  Thorax       Date:  2012-08-03       Impact factor: 9.139

7.  rrnDB: improved tools for interpreting rRNA gene abundance in bacteria and archaea and a new foundation for future development.

Authors:  Steven F Stoddard; Byron J Smith; Robert Hein; Benjamin R K Roller; Thomas M Schmidt
Journal:  Nucleic Acids Res       Date:  2014-11-20       Impact factor: 16.971

8.  Calypso: a user-friendly web-server for mining and visualizing microbiome-environment interactions.

Authors:  Martha Zakrzewski; Carla Proietti; Jonathan J Ellis; Shihab Hasan; Marie-Jo Brion; Bernard Berger; Lutz Krause
Journal:  Bioinformatics       Date:  2017-03-01       Impact factor: 6.937

9.  The adult cystic fibrosis airway microbiota is stable over time and infection type, and highly resilient to antibiotic treatment of exacerbations.

Authors:  Anthony A Fodor; Erich R Klem; Deirdre F Gilpin; J Stuart Elborn; Richard C Boucher; Michael M Tunney; Matthew C Wolfgang
Journal:  PLoS One       Date:  2012-09-26       Impact factor: 3.240

10.  Analysis of the airway microbiota of healthy individuals and patients with chronic obstructive pulmonary disease by T-RFLP and clone sequencing.

Authors:  Tetyana Zakharkina; Elke Heinzel; Rembert A Koczulla; Timm Greulich; Katharina Rentz; Josch K Pauling; Jan Baumbach; Mathias Herrmann; Christiane Grünewald; Hendrik Dienemann; Lutz von Müller; Robert Bals
Journal:  PLoS One       Date:  2013-07-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.